Biomolecular

Biomolecular is an early-stage biotechnology company focused on developing a "Programmable Medicine" platform to create next-generation therapeutics. Co-founded by industry veteran Dr. Michael J. Sofia, the chemist behind the hepatitis C drug Sovaldi, and Dr. David Walt, a pioneer in single-molecule analysis and co-founder of Illumina, the company leverages synthetic biology and advanced protein engineering. The platform aims to address complex diseases, including infectious diseases and oncology, by enabling the rapid design and optimization of drug candidates with high precision and specificity. Biomolecular operates at the intersection of computational design and molecular biology to streamline the drug discovery process and make medicines more predictable. The company is headquartered in Cambridge, Massachusetts, and is currently advancing its proprietary pipeline in stealth mode.